Skip to main content
. Author manuscript; available in PMC: 2018 Jun 20.
Published in final edited form as: Biochemistry. 2017 Jun 7;56(24):3058–3067. doi: 10.1021/acs.biochem.7b00334

Table 1.

Equilibrium Titration and Kinetic Parameters for the Ligand Binding to WT, Opt-WT, and Cys-less CYP3A4

WT opt-WT Cys-less
Equilibrium Titrations, Ks (μM)
RIT 0.05a 0.045 ± 0.008 0.047 ± 0.012
BEC 0.3b 0.77 ± 0.14 0.45 ± 0.06
MDZ
  0.1 M phosphate 4.8c 3.6 ± 0.1 0.73 ± 0.09
  0.6 M phosphate 1.8c 1.6 ± 0.1 0.22 ± 0.04
Ligand Binding Kinetics
RIT
  kfast(s−1) 1.24 ± 0.05 (70%)d 0.68 ± 0.02 (33%) 0.31 ± 0.03 (33%)
  kslow(s−1) 0.26 ± 0.02 (30%) 0.033 ± 0.003 (67%) 0.037 ± 0.005 (67%)
BEC
  kfast(s−1) 0.17 ± 0.02 (52%) 0.016 ± 0.003 (49%) 0.007 ± 0.001 (54%)
  kslow(s−1) 0.0089 ± 0.0014 (48%) 0.0016 ± 0.0004 (51%) 0.0013 ± 0.003 (46%)
MDZ, 0.1 M phosphate
  kfast(s−1) 1.50 ± 0.05 (70%) 0.19 ± 0.03 (43%) 0.15 ± 0.02 (40%)
  kslow(s−1) 0.022 ± 0.004 (30%) 0.021 ± 0.003 (57%) 0.022 ± 0.03 (60%)
MDZ, 0.6 M phosphate
  kfast(s−1) 3.4 ± 0.3 (82%) 0.26 ± 0.03 (49%) 0.27 ± 0.02 (43%)
  kslow(s−1) 0.23 ± 0.04 (18%) 0.027 ± 0.004 (51%) 0.036 ± 0.003 (57%)
First Electron Transfer from CPR
kfast(min−1) 1.20 ± 0.05 (65%) 0.72 ± 0.02 (85%) 1.22 ± 0.03 (64%)
kslow(min−1) 0.26 ± 0.02 (35%) 0.030 ± 0.003 (15%) 0.22 ± 0.02 (36%)
a

Determined previously.3

b

Determined previously.4

c

Determined previously.24

d

Percentage of absorbance change observed during the indicated kinetic phase.